Clinical Trial Update: A Phase III Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy [Phase 3]

View source ↗

Summary

A Phase III clinical trial evaluating HRS-1893 for obstructive hypertrophic cardiomyopathy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Hypertrophic Cardiomyopathy

Drugs mentioned

• HRS-1893

Snippet

Sponsor: Shandong Suncadia Medicine Co., Ltd. | Conditions: Obstructive Hypertrophic Cardiomyopathy | Phase 3 | Status: RECRUITING